Quintiles Transnational Corp. is moving along in setting up approval for its $1.7 billion buyout by Pharma Services Holdings, but the company has still not provided word on the status of the financing for the transaction. The pharmaceutical research and marketing firm said in its second quarter earnings conference call earlier this month that it hopes to hold a shareholder meeting to vote on the merger in the third quarter of this year. Sources said company officials did not address questions regarding the financing status during the conference call. Greg Connors, v.p. of investor relations, and a company spokeswoman did not return calls before press time.
August 24, 2003
